COVID-19 patients in the US."When we first started treating COVID-19 patients, we watched them get better or get worse, but we didn't know why," said Juan Reyes, MD, co-author of the study and assistant professor of medicine at the GW School of Medicine and Health Sciences."Some initial studies had come out of China showing certain biomarkers were associated with bad outcomes.
There was a desire to see if that was true for our patients here in the US," added Reyes.The research team evaluated 299 patients diagnosed with COVID-19 admitted to GW Hospital between March 12 and May 9, 2020.